Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Universal Response: At high doses, 100% of participants achieved at least 5% weight loss
After a brief round of pre-orders last month, reviews are flowing in from customers: "The appetite control
Retatrutide's diabetes relevance comes from its incretin and glucagon receptor profile
Phase 3 trials currently underway Seven TRIUMPH trials are testing retatrutide across multiple indications: TRIUMPH-1 : Obesity without diabetes TRIUMPH-2 : Type 2 diabetes TRIUMPH-3 : Obesity with type 2 diabetes TRIUMPH-4 : Obesity with knee osteoarthritis (COMPLETED, 28.7% weight loss) TRIUMPH-5 : Obstructive sleep apnea TRIUMPH-6 and 7 : Additional indications These trials will provide the definitive data for the commercial dosage chart
US$ 24.61
US$ 23.00
US$ 29.65
US$ 27.49
US$ 29.14
US$ 25.24
US$ 24.54
US$ 23.16
